Copyright © Inderes 2011 - present. All rights reserved.

Novo Nordisk

310.60 DKK

+1.32 %

Less than 1K followers

NOVO B

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

+1.32 %
-18.07 %
-4.50 %
-3.25 %
-4.69 %
-46.97 %
-35.85 %
+35.04 %
+24,847.79 %

Novo Nordisk is a producer of insulin for diabetes treatment. In addition to the specialist expertise in diabetes, the company produces drugs for hormone treatment as well as for hemophilia and bleeding disorders. The products are found on a global market and are sold under separate brands. Novo Nordisk was founded in 1923 and is headquartered in Bagsværd, Denmark.

Read more
Market cap
1.39T DKK
Turnover
1.73B DKK
Revenue
309.06B
EBIT %
41.3 %
P/E
13.47
Dividend yield-%
3.77 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.3
2026

General meeting '26

27.3
2026

Half year dividend

6.5
2026

Interim report Q1'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
“Novo Nordisk (NOVOb.CO), said on Monday it has filed a lawsuit against U.S. telehealth company Hims & Hers (HIMS.N), for infringing on the Danish group’s patents. “Novo Nordisk is asking the court to permanently ban Hims from selling unapproved, compounded drugs that infringe our...
2/9/2026, 12:35 PM
by 916
42
Hims & Hers is backing off: WKZO | Everything Kalamazoo | 590 AM · 106.9 FM Hims to stop offering GLP-1 pill after FDA warned of crackdown By Anusha Shah and Amina Niasse Feb 7 (Reuters) - Online telehealth company Hims & Hers on Saturday reversed course on its launch of a $49 compounded...
2/8/2026, 5:59 AM
41
There is not something in the water in Denmark, besides the annoying levels of lime that destroys your household applies I do also follow Terry Smith’s commentary, and I do agree with him, especially with regard his views of leadership of Novo. What has most surprised me (in a negative...
2/7/2026, 7:46 AM
by 916
40
Novo Nordisk’s stock is rising rapidly as Hims & Hers abandons its copycat drug. Tärkeimmät talousuutiset | Kauppalehti – 9 Feb 26 PÖRSSIT: Novo Nordisk kiitää Euroopan pörssien nousuavauksessa Novo Nordiskin osake kohoaa kovaa vauhtia Hims & Hersin luopuessa kopiolääkkeestä. Shares...
2/9/2026, 8:37 AM
by Index
32
Novo Nordisk to start manufacturing the Wegovy weight-loss pill in Ireland for markets outside the United States. Good, good! The Irish Times Novo Nordisk set to make Wegovy weight loss pill in Ireland for markets... Swiss drugmaker’s CEO says launch of weight loss pill has been ...
yesterday
by Beginner
22
Jussi Halme has made a video about Novo Nordisk. Pharmaceutical giant Novo Nordisk, long known as an unwavering sensation in European stock market history, has drifted into unprecedented turbulence. Until recently, the company’s market value approached 600 billion dollars, but in...
2/8/2026, 7:27 AM
by Sijoittaja-alokas
13
The current CEO Maziar Mike Doustdar seems to be bolder than his predecessor in advancing Novo’s interests. In itself, if that lawsuit results in a major win relatively quickly, the impact could be surprisingly positive as early as 2026, even though the guidance was only issued last...
2/9/2026, 1:53 PM
by Divinesia
12
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.